English press releases

RESTYLANE®, the Original Stabilized Hyaluronic Acid Filler, Celebrates 25 Years of Unmatched Achievement

The unsurpassed NASHA™ technology, which is still used today as the benchmark for fillers, was pioneered by Galderma LAUSANNE, Switzerland–(BUSINESS WIRE)– Galderma, the world’s largest...

SES Joins Forces with SoftBank Corp. to Deliver Live Sporting Events Into Japan

SES to use its global satellite and terrestrial infrastructure to aggregate and deliver sports events live to SoftBank so that millions across Japan can enjoy...

Launch of Space Data Marketplace

Bringing together the best-in-class technological and industrial expertise in France and Europe to accompany the revolution of the space sector PARIS–(BUSINESS WIRE)– Today marks the...

ABB Launches the World’s Fastest Electric Car Charger

Can deliver 100km of range in less than three minutes Only charger designed explicitly to charge up to four vehicles at once Ideal for refueling...

Gopher agrees to acquire Finalto for USD 250 million

HONG KONG–(BUSINESS WIRE)– NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO...

Shionogi to Present In Vitro and Real-World Data at IDWeek 2021 Demonstrating Activity of FETCROJA® (cefiderocol) Against Gram-Negative Pathogens

OSAKA, Japan–(BUSINESS WIRE)– Shionogi & Co., Ltd. (hereafter “Shionogi”) today announces that 11 abstracts on FETCROJA® (cefiderocol) will be shared at IDWeek. The meeting will...

Alkira and Check Point Software Technologies Collaborate to Bring Enterprise-Class Security to Cloud Workloads

Solution Simplifies Security for Cloud, Multi-Cloud and On-Premises Networking Environments SAN JOSE, Calif.–(BUSINESS WIRE)– Cloud networking pioneer Alkira® and Check Point Software Technologies (NASDAQ: CHKP),...

ViiV Healthcare presents three-year switch data for Dovato (dolutegravir/lamivudine) confirming long-term, non-inferior efficacy with no virologic failure versus continuation of TAF-based regimens of at least three drugs

The Phase III TANGO study is the third trial to provide long-term evidence for Dovato, reinforcing its use as a viable switch option for people...

CGTN Channels to Switch to HD in SES and Globecast Renewal Agreement

For the first time, three CGTN channels will be broadcast in HD via SES’s prime neighbourhood of ASTRA 19.2 degrees East LUXEMBOURG–(BUSINESS WIRE)– Audiences across...

Harbor Spring Capital, LLC Comments on Urgent Need for More Substantial Change at Intertrust N.V. Following Announcement of Share Repurchase Program

After Extensive Period of Private Engagement, Long-Term Shareholder Publicly Issues 20 September 2021 Letter to Intertrust N.V.’s Supervisory and Management Boards for the Information and...

Galderma Presents New Nemolizumab Data at EADV Reinforcing Rapid Onset of Action and Consistent Relief of Symptoms for People With Prurigo Nodularis and Atopic Dermatitis

Six abstracts; including new phase 2 data for nemolizumab across PN and AD and new real-world evidence highlighting the PN disease burden being presented Prurigo...

Lunaphore Spatial Biology Technologies to be Featured at Spatial Biology US Conference

LAUSANNE, Switzerland–(BUSINESS WIRE)– Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced several presentations featuring the company’s...

Woven Planet Holdings, a Subsidiary of Toyota, Acquires Vehicle Operating System Developer Renovo Motors

Acquisition to Provide Additional Resources to Power World-Class Technology and Build the Safest Mobility in the World TOKYO & CAMPBELL, Calif.–(BUSINESS WIRE)– Woven Planet Holdings,...

Seagen Announces Last Patient Enrolled in Phase 2 MOUNTAINEER Trial Evaluating TUKYSA® (Tucatinib) Regimen in HER2-Positive Metastatic Colorectal Cancer

– Trial Designed to Support an Accelerated Approval Application in the U.S. – BOTHELL, Wash.–(BUSINESS WIRE)– Seagen Inc. (Nasdaq: SGEN) today announced it completed patient...

Galderma to Unveil Ground-breaking Data From Across Its Leading Dermatology Portfolio and Showcase Major Update for Sensitive Skincare Brand CETAPHIL® at the 2021 EADV Congress

Galderma will host six symposia and three industry hubs, and present several scientific posters demonstrating its expertise and its commitment to advancing dermatology The company...